News & Events

Grants and scholarships
Calling all early career researchers! The Bupa Health Foundation aims to not only support research through funding and partnerships, but also to develop the capabilities, skills and networks of researchers to improve the translation of their findings so as to have real impact on health and care. The Bupa Health Foundation is seeking nominations for its 2019 Emerging Health Research Awa...
Read more
Infectious disease
What is Parechovirus? Parechovirus is similar to the better known enteroviruses – viruses that cause common infectious diseases such as hand, foot and mouth diseases in children. According to research published in the Medical Journal of Australia, epidemics of human parechovirus (HPeV) causing severe disease in young children have occurred every 2 years in Australia since 2013. There are 17...
Read more
Gene Therapy
The need for effective treatments for children with rare genetic diseases has been a long and challenging road in research and the community. With the advancement of technology, research is now a step closer to an answer – gene therapy. A major game changer in medicine, gene therapy was recently addressed at the National Press Club of Australia by Dr Elizabeth Finkel, who is the first journali...
Read more
Events
‘Approximately one in ten children in Australia meet criteria for a neurodevelopmental disorder’ Professor Adam Guastella, Michael Crouch Chair in Child and Youth Mental Health, clinical psychologist and clinical trials specialist based at Westmead Children’s Hospital and the Brain and Mind Centre, University of Sydney is leading a national effort where leading experts from universities and he...
Read more
Grants and Scholarships
Round 2 of the Sydney Partnership for Health, Education, Research & Enterprise (SPHERE) Translational Research Fellowship Scheme (TRFS) is now open! The SPHERE TRFS intends to support healthcare professionals/clinicians within research active units to undertake high-quality, clinically relevant research. The fellowship funding will make provisions for salary support, commensurate with the...
Read more
- Achieved primary efficacy measure with both EPIDIOLEX doses as compared to placebo - - Represents the fifth consecutive positive Phase 3 pivotal trial for EPIDIOLEX - - Expect to file sNDA in Q4 2019 -   Carlsbad, CA, May 6, 2019: GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the scien...
Read more
Medicinal Cannabis
Medicinal Cannabis: Positive results in treatment of children with seizures from Tuberous Sclerosis Complex (TSC) A phase 3 clinical trial has shown that the cannabis-based medicine Epidiolex ® (cannabidiol oral solution or CBD) manufactured and supplied by GW pharmaceuticals was successful in the treatment of seizures associated with Tuberous Sclerosis Complex (TSC). TSC is a rare genetic...
Read more